MITHRA COMPLETES RECRUITMENT FOR estelle® phase iii study in US & Canada
Estelle® Phase III study in US/Canada remains on track to report top line data in Q1 2019 Study recruited 2148 women in…
Estelle® Phase III study in US/Canada remains on track to report top line data in Q1 2019 Study recruited 2148 women in…
Mithra (Euronext Brussels: MITRA), a company specialized in Women's Health, today announces that the Australian Patent O…
Mithra (Euronext Brussels: MITRA), a company specialized in Women's Health, announces that it has completed recruitment…
/pressemitteilung/pdf/69557/meldung.pdf
/pressemitteilung/pdf/59383/meldung.pdf
/pressemitteilung/pdf/56005/meldung.pdf